Clinical Trial Update: Low-Dose rtPA to Treat Blood Clots in Major Arm or Neck Veins [Phase 1]

View source ↗

Summary

A Phase 1 trial update reports results of using low-dose alteplase (rtPA) to treat venous thrombosis in major arm or neck veins. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thrombosis

Drugs mentioned

• Alteplase (alteplase)

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Thrombosis | Phase 1 | Status: COMPLETED